Morbidity and Mortality Weekly Report (MMWR)

Male circumcision is an important preventive strategy in lifelong partial protection against heterosexually acquired HIV infection among males. This report describes how the prevalence of male circumcision increased in Chókwè District in southern Mozambique.

Although access to in-person, hybrid, and virtual learning modes varied throughout the school year, during January-April 2021, access to full-time, in-person learning increased 37% for non-Hispanic White students, 31% for non-Hispanic Black students, 22% for Hispanic students, and 27% for students of other race/ethnicities.

Among 26,174 surveyed state, tribal, local, and territorial public health workers, 53% reported symptoms of at least one mental health condition in the past 2 weeks. Symptoms were more prevalent among those who were unable to take time off from work or who felt bullied, threatened, or harassed because of work.

This report describes HIV testing trends in people with commercial insurance or Medicaid.

This report describes an analysis of 2017-2019 Behavioral Risk Factor Surveillance System data on Women's ongoing or potential need for contraceptive services.

In 2019, among adults aged ≥18 years, women (19%) were more likely than men (16%) not to get needed dental care because of cost in the past 12 months.

This report describes COVID-19 surveillance and investigations in the workplace in Washington State.

MMWR erratum volume 70, number 23.

Overall, 34% of adults aged 18-39 years reported having received a COVID-19 vaccine. Adults aged 18-24 years, as well as non-Hispanic Black adults and those with less education, no health insurance, and lower household incomes, had the lowest reported vaccination coverage and intent to get vaccinated. Concerns about vaccine safety and effectiveness were commonly cited barriers to vaccination.

By May 22, 2021, 57% of U.S. adults aged 18 and older had received ≥1 COVID-19 vaccine doses; coverage was lower and increased more slowly over time among younger adults. If the current rate of vaccination continues through August, coverage among young adults will remain substantially lower than among older adults.

This report describes mental health among parents and caregivers of adults during the COVID-19 pandemic.

This report describes disparities in fatal drowning rates among persons aged ≤29 years in the United States.

This report describes trends in hepatitis A cases among men who have sex with men.

This report describes the percentage of adults aged ≥50 years who ever received a shingles vaccine in the United States.

MMWR Erratum Volume 70, Number 14

This report describes the percentage of adults aged ≥50 years who ever received a shingles vaccine in the United States.

MMWR Erratum Volume 70, Number 14

This report describes disparities in fatal drowning rates among persons aged ≤29 years in the United States.

This report describes mental health among parents and caregivers of adults during the COVID-19 pandemic.

This report describes trends in hepatitis A cases among men who have sex with men.

As of May 2021, 16% of pregnant people identified in CDC's Vaccine Safety Datalink had received ≥1 dose of a COVID-19 vaccine during pregnancy in the U.S. Vaccination was lowest among Hispanic people (12%), non-Hispanic Black people (6%), and people aged 18-24 years (6%), and highest among non-Hispanic Asian people (25%) and people aged 35-49 years (23%).

During the COVID-19 pandemic, emergency department (ED) visits for suspected suicide attempts increased among adolescents aged 12-17 years, especially girls. During February-March 2021, suspected suicide attempt ED visits were 51% higher among girls aged 12-17 years than during 2019; among boys aged 12-17 years, suspected suicide attempt ED visits increased 4%.

This report describes trends in administered childhood and adolescent vaccinations during the COVID-19 pandemic.

This report describes rubella incidence in European regions for the years 2005 to 2019.

This report describes the percentage of children who wear glasses or contacts by age and sex.

This report describes surveillance for SARS-CoV-2 variants circulating in the United States.

By May 2021, 69%, 45%, and 26% of adults aged ≥65, 50-64, and 18-49 years were fully vaccinated. From November-December 2020 to April-May 2021, the rate ratios of COVID-19 incidence, emergency department visits, hospital admissions, and deaths among persons aged ≥65 (≥70 for hospitalizations) to persons aged 18-49 years declined 40%, 59%, 65%, and 66% respectively.

COVID-19 adolescent hospitalization rates peaked at 2.1 per 100,000 in early January 2021, declined to 0.6 in mid-March, and rose to 1.3 in April. Among hospitalized adolescents, nearly one-third required intensive care unit admission and 5% required invasive mechanical ventilation, but no associated deaths occurred.

This report describes how HIV-positive patients with severe HIV disease were more likely to develop severe COVID-19 or die of COVID-19.

This report describes estimated HIV infections in the United States during 1981-2019.

This report describes the effect of policy, funding, and strategy changes on COVID-19 surveillance in the South Sudan.

This report describes the percentage of adults who are worried about paying medical bills when they get ill or have an accident.

Based on the national trend in ESRD deaths during the first 7 months of the U.S. COVID-19 pandemic (February-August 2020), an estimated 8.7-12.9 excess deaths per 1,000 patients or 6,953-10,316 excess deaths in a population of 798,611 U.S. ESRD patients occurred.

Disparities in county-level vaccination coverage by social vulnerability have increased as vaccine eligibility has expanded. By May 2021, vaccination coverage was lower among adults living in counties with low socioeconomic status and higher percentages of households with children, single parents, and people with disabilities.

This report describes the percentage of adults aged 18-26 years who received a human papillomavirus vaccine, by race and Hispanic origin and sex.

This report describes how Sub-Saharan African countries have overcome challenges to initiate and scale up HIV viral load testing to monitor patients receiving Antiretroviral therapy.

This report describes the impact of COVID-19 on HIV viral load testing in PEPFAR-supported countries.

This report describes racial/ethnic disparities in breastfeeding initiation across states.

As of April 30, 2021, approximately 101 million people in the U.S. had been fully vaccinated against COVID-19. Almost 10,300 COVID-19 vaccine breakthrough infections were reported from 46 states and territories. Vaccine breakthrough infections occur in only a small fraction of all vaccinated people.

Utah implemented two high school COVID-19 testing programs to sustain in-person instruction and extracurricular activities. During November 30, 2020-March 20, 2021, among 59,552 students who received testing, 1,886 (3.2%) had a positive result. These programs facilitated the completion of approximately 95% of high school athletic events and saved an estimated 109,752 in-person instruction student-days.

COVID-19 incidence was 37% lower in schools that required teachers and staff to use masks and 39% lower in schools that improved ventilation. Ventilation strategies associated with lower school incidence included dilution methods alone (35% lower incidence) or in combination with filtration methods (48% lower incidence).

This report describes death rates for falls, motor vehicle traffic, firearms, and drug poisonings in the United States.

This report describes COVID-19 cases and outbreaks in child care facilities in the District of Columbia.

This report describes outbreaks caused by pathogens or chemicals in treated recreational water.

This report describes updated recommendations for the use of self-administered injectable contraception.

COVID-19 vaccination coverage was lower in rural counties (38.9%) than in urban counties (45.7%); disparities persisted among age groups and by sex.

The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.

In May 2021, after a systematic review of all available data, the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years for the prevention of COVID-19.

After the first 3.5 months of the U.S. COVID-19 vaccination program, 79.1% of adults aged ≥65 years had received ≥1 dose, with higher vaccination initiation among men. Counties with lower vaccination initiation rates had higher percentages of older adults with social vulnerabilities.

This report describes how COVID-19 community-based testing programs can help reach underrepresented groups with limited access to testing.